Pemetrexed and Gemcitabine as Combination Therapy for the Treatment of Group3 Medulloblastoma

Cancer Cell - United States
doi 10.1016/j.ccr.2014.02.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Evaluation of Treatment for Childhood Medulloblastoma, With Special Reference to Combination Therapy With Interferon and Radiation.

Neurologia Medico-Chirurgica
SurgeryNeurology
1987English

P3.17-22 Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Systematic Review of Gemcitabine and Taxanes Combination Therapy Randomized Trials for Metastatic Breast Cancer

SpringerPlus
Multidisciplinary
2014English

Improved Therapy for Medulloblastoma: Targeting Hedgehog and PI3K-mTOR Signaling Pathways in Combination With Chemotherapy

Oncotarget
Oncology
2018English

Proton Beam Therapy for Medulloblastoma

The Lancet Oncology
Oncology
2016English

Combination of Idarubicin, Vinblastine, Dacarbazine, and Gemcitabine (IVDG) as Therapy for Elderly Patients With Hodgkin Lymphoma With Cardiac and Pulmonary Comorbidity

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Pemetrexed as Indispensable Drug for the Treatment of Non-Squamous Non-Small Cell Lung Cancer; The Role in Induction and Maintenance Therapy

Cancer Cell & Microenvironment
2014English

Combination Studies With Gemcitabine in the Treatment of Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
1998English

In Vitro and in Vivo Efficacy of Afatinib as a Single Agent or in Combination With Gemcitabine for The treatment of Nasopharyngeal Carcinoma

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy